PolyPid (PYPD) EBIT (2019 - 2026)
PolyPid's EBIT was $7.85 million in Q2 2026, down 16.5% from $9.4 million a year earlier but up 1.1% from the prior quarter.
Powered by 
Analysis
PolyPid (PYPD) EBIT (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, PolyPid's EBIT was $31.59 million through Jun 30, 2026, down 3.1% year-over-year; for FY2025, it was $32.97 million, up 17.6% from FY2024.
- EBIT shows a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
- In earlier years, EBIT was $28.03 million in FY2024 (+22.6%), $22.87 million in FY2023 (-41.2%), $38.89 million in FY2022 (-9.9%) and $43.15 million in FY2021 (+64.2%).
- Quarterly EBIT has moved between $5.26 million (Q3 2023) and $13.65 million (Q4 2021) over five years.
- Compared with a year earlier, EBIT was higher in seven of the last eight quarters, with growth averaging 17.7%.
- The best year-over-year quarter for EBIT over five years was Q4 2021 (growth of 73.1%); the worst was Q4 2022 (a decline of 51.6%).
- Per Business Quant data, PYPD's EBIT in the three quarters before Q2 2026 was $7.76 million (Q1 2026), $8.53 million (Q4 2025) and $7.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.70 Bn | 1,135.28 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 633.99 Bn | 552.52 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 502.96 Bn | 476.07 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 377.09 Bn | 331.47 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 303.78 Bn | 267.77 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 266.66 Bn | 240.35 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 241.39 Bn | 196.79 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 172.37 Bn | 119.01 Bn | 10.94 Bn | 4.27 Bn |
| 10 | PolyPid | 83.39 Mn | 51.87 Mn | - | -23.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.37 Mn |
| Mar 31, 2026 | 7.76 Mn |
| Dec 31, 2025 | 8.53 Mn |
| Sep 30, 2025 | 7.46 Mn |
| Jun 30, 2025 | -9.40 Mn |
| Mar 31, 2025 | 7.58 Mn |
| Dec 31, 2024 | 8.22 Mn |
| Sep 30, 2024 | 7.39 Mn |
| Jun 30, 2024 | -6.12 Mn |
| Mar 31, 2024 | 6.30 Mn |
| Dec 31, 2023 | 6.00 Mn |
| Sep 30, 2023 | 5.26 Mn |
| Jun 30, 2023 | -5.82 Mn |
| Mar 31, 2023 | 5.79 Mn |
| Dec 31, 2022 | 6.61 Mn |
| Sep 30, 2022 | 8.76 Mn |
| Jun 30, 2022 | -11.56 Mn |
| Mar 31, 2022 | 11.95 Mn |
| Dec 31, 2021 | 13.65 Mn |
| Sep 30, 2021 | 10.06 Mn |
API Access
PolyPid EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=PYPD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "PYPD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=PYPD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();